Entry Detail



General Information

Database ID:exR0201391
RNA Name:hsa-miR-129-5p
RNA Type:miRNA
Chromosome:chr7
Starnd:+
Coordinate:
Start Site(bp):128207876End Site(bp):128207896
External Links:hsa-miR-129-5p



Disease Information

Disease Name:Mild Cognitive Impairment
Disease Category:Other Diseases
MeSH ID:D060825
Type:Psychiatry and Psychology Category/Mental Disorders
Alias:Cognitive Dysfunction//Cognitive Dysfunctions//Dysfunction, Cognitive//Dysfunctions, Cognitive//Cognitive Impairments//Cognitive Impairment//Impairment, Cognitive//Impairments, Cognitive//Mild Cognitive Impairment//Cognitive Impairment, Mild//Cognitive Impairments, Mild//Impairment, Mild Cognitive//Impairments, Mild Cognitive//Mild Cognitive Impairments//Mild Neurocognitive Disorder//Disorder, Mild Neurocognitive//Disorders, Mild Neurocognitive//Mild Neurocognitive Disorders//Neurocognitive Disorder, Mild//Neurocognitive Disorders, Mild//Cognitive Decline//Cognitive Declines//Decline, Cognitive//Declines, Cognitive//Mental Deterioration//Deterioration, Mental//Deteriorations, Mental//Mental Deteriorations



Expression Detail

GEO ID:GSE120584
Description:Risk prediction models for dementia constructed by supervised principal component analysis using miRNA expression data
Experimental Design:Disease vs Control
Case Disease Type:Alzheimer's Disease
Case Disease SubType:NA
Case Sample:Mild Cognitive Impairment
Control Sample:Normal
Number of Case:1021
Number of Control:288
Number of Samples:1309





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
TNRC6B
chr22
40044817
40335808
+
KRIT1
chr7
92198969
92246166
-
SLC7A2
chr8
17497088
17570573
+
TRIM71
chr3
32817997
32897824
+
SHCBP1
chr16
46578591
46621379
-
NEDD4
chr15
55826922
55993746
-
ZNF605
chr12
132918306
132956306
-
DDX18
chr2
117814691
117832377
+
CPSF7
chr11
61402641
61430031
-
RAD1
chr5
34905260
34918989
-
UBN2
chr7
139230356
139308236
+
DEGS1
chr1
224175756
224193441
+
SEC62
chr3
169966635
169998373
+
CRK
chr17
1420689
1463162
-
SLC35E1
chr19
16549831
16572415
-
TRIM14
chr9
98069275
98119222
-
ALDH5A1
chr6
24494867
24537207
+
UFL1
chr6
96521595
96555276
+
DUSP14
chr17
37489891
37513501
+
WSB1
chr17
27294076
27315926
+
DNAJC24
chr11
31369840
31432835
+
CHURC1
chr14
64914361
64944591
+
MLEC
chr12
120687149
120701859
+
CAMTA1
chr1
6785454
7769706
+
THUMPD1
chr16
20702816
20742084
-
EIF4A1
chr17
7572706
7579006
+
ACER3
chr11
76860867
77026797
+
TTPAL
chr20
44475874
44494603
+
PDS5A
chr4
39822863
39977956
-
FBXW7
chr4
152320544
152536092
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000943
chr19
47421744
47440665
+
hsa_circ_0001168
chr20
47691321
47707559
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC004069.1
chr4
105137280
105140619
-
AC097634.1
chr3
71584943
71587409
+
AL049795.2
chr1
32170733
32176568
+
FGD5-AS1
chr3
14920347
14948424
-
MALAT1
chr11
65497688
65506516
+
NEAT1
chr11
65422774
65445540
+
NUTM2A-AS1
chr10
87201647
87342612
-
OIP5-AS1
chr15
41283990
41309737
+
TBC1D3P1-DHX40P1
chr17
59962363
60018975
-
TUG1
chr22
30969245
30979395
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE120584
Sample Source:Blood
Source Fraction:Serum
Platform:GPL21263
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:2532
Sample treatment protocol:NA
RNA Extract protocol:Total RNA was extracted each from 300uL serum samples using 3D-Gene® RNA extraction reagent from liquid sample kit (Toray Industries, Inc.).
RNA library preparation protocol:miRNA was labeled using 3D-Gene® miRNA Labeling kit in accordance with the manufacturer's instructions.



Reference

PMID:30820472
Title:Risk prediction models for dementia constructed by supervised principal component analysis using miRNA expression data
Author:Shigemizu D, Akiyama S, Asanomi Y, Boroevich KA, Sharma A, Tsunoda T, Matsukuma K, Ichikawa M, Sudo H, Takizawa S, Sakurai T, Ozaki K, Ochiya T, Niida S
Journal:Commun Biol. 2019 Feb 25;2:77.
Description:we investigated potential miRNA biomarkers and constructed risk prediction models, based on a supervised principal component analysis (PCA) logistic regression method, according to the subtype of dementia